Medipal revised its net profit forecast for the fiscal year ending March 27 upward to ¥43 billion from ¥39 billion.

Medipal Holdings Corporation <7459> announced a revision to its earnings forecast for the fiscal year ending March 2027, raising its net profit attributable to owners of parent from ¥39 billion to ¥43 billion. The tender offer for shares of PALTAC Corporation <8283> has been completed. Medipal will now proceed with squeeze-out procedures to make PALTAC a wholly owned subsidiary (scheduled for around August 2026). As a result, the portion previously attributed to non-controlling interests will be fully attributable to Medipal, contributing to an increase in net profit attributable to owners of parent.

Fisco JapanJul 15 05:03

Express News | Casy Co Ltd 6-Mth Group Operating Loss 6 Mln Yen Vs Profit 13 Mln Yen, 2025/26 Forecast Loss 133 Mln Yen

BreakingsJul 14 16:00

Express News | Casy Co Ltd 6-Mth Group Net Loss 5 Mln Yen Vs Profit 9 Mln Yen, 2025/26 Forecast Loss 139 Mln Yen

BreakingsJul 14 16:00

Casy: Half-Year Report – Fiscal Year 13 (December 1, 2025 – November 30, 2026)

EDINETJul 14 16:00 · Announcements

Casy: Confirmation letter

EDINETJul 14 16:00 · Announcements

Casy: FY2026 Second Quarter Earnings Presentation

JPXJul 14 16:00 · Announcements